In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells

International Journal of Oncology

Volumn 31, Issue 2, 2007, Pages 451-460

  Salvi, Alessandro ^a   Arici, Bruna ^a   Portolani, Nazario ^a   Giulini, Stefano Maria ^a   De Petro, Giuseppina ^a   Barlati, Sergio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Anti sense RNA; c met; Hepatocellular carcinoma cells; RNA interference

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; RNA; SCATTER FACTOR RECEPTOR;

ARTICLE; BIOLOGICAL MODEL; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MODELS, GENETIC; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MET; RNA; RNA INTERFERENCE; TRANSFECTION;

EID: 35148864569     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.2.451     Document Type: Article

References (41)

1. Thorgeirsson SS and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346, 2002. (Pubitemid 35154440)
2. Pawlik TM, Esnaola NF and Vauthey J: Surgical treatement of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10: 74-80, 2004.
3. Lin JC, Naujokas M, Zhu H, Nolet S and Park M: Intron-exon structure of the MET gene and cloning of an alteratively-spliced Met isoform reveals frequent exon-skipping of a single large internal exon. Oncogene 16: 833-842, 1998. (Pubitemid 28102586)
4. Liu Y: The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215: 159-169, 1998. (Pubitemid 28359229)
5. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A and Thashiro EK: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
6. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E and Mirossay L: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
7. Gao CF and Vande Woude GF: HGF/SF-Met signaling in tumor progression. Cell Res 15: 49-51, 2005.
8. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G and Choyke P: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997.
9. Lee J H, Han S U, Cho H, Jennings B Gerrard B, Dean M, Schmidt L, Zbar B and Vande Woude JF: A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 19: 4947-4953, 2000.
10. Park WS, Dong SM, Kim SY, Na EY and Shin SM: Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res 59: 307-310, 1999.
11. Grigioni WF, Fiorentino M, D'Errico A, Ponzetto A, Crepaldi T, Prat M and Comoglio PM: Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology 21: 1543-1546, 1995.
12. Okano J, Shiota G and Kawasaki H: Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver 19: 151-159, 1999. (Pubitemid 29139769)
13. Luo YQ, Wu MC and Cong WM: Gene expression of hepatocyte growth factor and its receptor in HCC and non-tumorous liver tissues. World J Gastroenterol 5: 119-121, 1999.
14. Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM and Barlati S: u-PA and c-met mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Int J Cancer 87: 644-649, 2000. (Pubitemid 30620405)
15. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höler H, Janicke F and Graeff H: Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78: 285-296, 1997.
16. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M and Nagamine Y: The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56: 104-132, 1999. (Pubitemid 29471930)
17. De Petro G, Copeta A and Barlati S: Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 213: 286-294, 1994. (Pubitemid 24227410)
18. Michalopoulos GK and De Frances MC: Liver regeneration. Science 276: 60-66, 1997.
19. Arens N, Gandhari M, Bleyl U and Hildenbrand R: In vitro suppression of urokinase plasminogen activator in breast cancer cells - a comparison of two antisense strategies. Int J Oncol 26: 113-119, 2005.
20. Kushner DM and Silverman RH: Antisense cancer therapy: the state of the science. Curr Oncol Rep 2: 23-30, 2000.
21. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 39: 806-811, 1998.
22. Dorsett Y and Tuschl T: siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329, 2004. (Pubitemid 38499759)
23. Semizarov D, Kroeger P and Fesik S: siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res 32: 3836-3845, 2004. (Pubitemid 39199076)
24. Tuschl T: Expanding small RNA interference. Nat Biotechnol 20: 446-448, 2002.
25. Zeng Y, Yi R and Cullen BR: Micro-RNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 100: 9779-9784, 2003. (Pubitemid 37087018)
26. Barlati S, Zoppi N, Copeta A, Tavian D, De Petro G and Colombi M: Quantitative in situ hybridization for the evaluation of gene expression in asynchronous and synchronized cell cultures and in tissue sections. Histol Histopathol 14: 1231-1240, 1999.
27. Salvi A, Arici B, De Petro G and Barlati S: Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. Mol Cancer Ther 3: 671-678, 2004. (Pubitemid 39193747)
28. De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM and Barlati S: Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. Cancer Res 58: 2234-2239, 1998. (Pubitemid 28232913)
29. Salvi A, Arici B, Alghisi A, Barlati S and De Petro G: RNA interference against urokinase in hepatocellular carcinoma xenografs in nude mice. Tumor Biol 28: 16-26, 2007. (Pubitemid 46012462)
30. Hwang LH: Gene therapy strategies for hepatocellular carcinoma. J Biomed Sci 13: 453-468, 2006.
31. Boccaccio C and Comoglio PM: Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev 6: 637-645, 2006. (Pubitemid 44140861)
32. Gentile A and Comoglio PM: Invasive growth: a genetic program. Int J Dev Biol 48: 451-456, 2004.
33. Tavian D, Salvi A, De Petro G and Barlati S: Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells. Cancer Gene Ther 10: 112-120, 2003. (Pubitemid 36228258)
34. Nellen W and Sczakiel G: In vitro and in vivo action of antisense RNA. Mol Biotechnol 6: 1-14, 1996.
35. Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM and Gallick GE: Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63: 2990-2996, 2003.
36. Zhang SZ, Pan FY, Xu JF, Yuan J, Guo SY, Dai G, Xue B, Shen WG, Wen CJ, Zhao DH, Li CJ: Knockdown of c-met by adenovirus small interfering RNA inhibits hepato-cellular carcinoma in vitro and in vivo. Mol Cancer Ther 4: 1577-1584, 2005.
37. Wang R, Ferrell LD, Faouzi S, Maher JJ and Bishop JM: Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153: 1023-1034, 2001.
38. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M and Rao JS: RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival and tumorigenesis in vivo. J Biol Chem 43: 36529-36540, 2005.
39. Jeffers M, Rong S and Woude GFV: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor scatter factor/Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125, 1996. (Pubitemid 26061683)
40. Aebersold DM, Landt O, Berthou S, Gruber G, Beer KT, Greiner RH and Zimmer Y: Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. Oncogene 22: 8519-8523, 2003.
41. Qian LW, Mizumoto K, Inadone N, Nagai E, Sato N, Matsumoto K, Nakamura T and Tanaka M: Radiation stimulates HGF receptor/c-MET expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cells. Int J Cancer 104: 542-549, 2003.